Last reviewed · How we verify
NCT03677297
"Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects"
Phase 4 trial testing Rosuvastatin in Adult Periodontitis in 10 participants. Completed in 10 November 2017.
1 August 2017
Quick facts
| Lead sponsor | Dr. D. Y. Patil Dental College & Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 28 January 2016 |
| Primary completion | 1 August 2017 |
| Estimated completion | 10 November 2017 |
| Sites | 1 location across India |
Drugs / interventions tested
- Rosuvastatin (rosuvastatin) — full drug profile →
Conditions studied
- Adult Periodontitis — all drugs for Adult Periodontitis →
Sponsor
Dr. D. Y. Patil Dental College & Hospital
Who can join
Adults 30 to 50, any sex, with Adult Periodontitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study aims to evaluate clinical and radiographic effectiveness of 1.2% Rosuvastatin gel in the treatment of Infrabony defects in chronic periodontitis patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effects of statins on dental and oral health: a review of preclinical and clinical studies.
Tahamtan S, Shirban F, Bagherniya M, Johnston TP, et al · · 2020 · cited 52× · PMID 32252793 · DOI 10.1186/s12967-020-02326-8
Verify or expand the search:
- PubMed search for NCT03677297
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Rosuvastatin
Trials testing the same drug.
- NCT07474649 — A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events · Phase 3 · not yet recruiting
- NCT07534592 — A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants · Phase 1 · not yet recruiting
- NCT07515339 — A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dab · Phase 1 · not yet recruiting
- NCT07303816 — Statins to Prevent Cancer Associated Blood Clots · Phase 4 · not yet recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
Other Dr. D. Y. Patil Dental College & Hospital trials
Trials by the same sponsor.
- NCT06043687 — Efficacy of Herbal Dentifrice in Treatment of Chronic Periodontitis · Phase 3 · completed
- NCT05852366 — Efficacy of Herbal Dentifrice for Management of Dentinal Hypersensitivity · Phase 3 · completed
- NCT05185206 — Comparative Evaluation of the Post Operative Sensitivity of Cention-N(Commercially Available Restorative Material) Using · NA · unknown
- NCT04319575 — Comparison of Triple Antibiotic Paste With Combination of Chitosan and Calcium Hydroxide as a Root Canal Disinfectant · Phase 2, PHASE3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03677297 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. D. Y. Patil Dental College & Hospital
- Last refreshed: 19 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03677297.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing